Research Areas

Primary Outcomes Within a 2-Year Period In Subjects With Diabetes Mellitus Treated with An Inhaled Investigational Medication or Usual Antidiabetic Treatment and In Subjects With Abnormalities in Glucose Control

Comparison of Efficacy, Safety, and Tolerability of Two Formulations of an Investigational Medication in Comparison to NPH Insulin in Insulin Dependent Diabetes Mellitus (IDDM) Patients Receiving Basal Bolus Insulin Treatment

A Long-Term, Multicenter Study to Evaluate the Tolerability of Investigational Medication in Patients With Type I Diabetes Mellitus

A Phase III Long-term Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients with Type 1 Diabetes Mellitus.

Phase II Dose-Response Study of a Topical Gel Formulation of Nitroglycerin, MQX-503 in the Treatment of Raynauds Phenomenon

Collection of normal blood samples for use in genetic studies for Lung Cancer

A Randomized, Double-Blind, Active Control, Parallel Arm, 90 Day Safety Study of An Investigational Medication Immediate Release (IR) or Oxycodone IR in Subjects with Chronic Pain from Low Back Pain (LBP) or Osteoarthritis (OA) of the Hip or Knee.

A Fifty-Two Week, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Study to Compare the Effects of Sibutramine With Those of Placebo in Mild to Moderate Obese Patients Whose Hypertension is Controlled by an Angiotensin-Converting Enzyme Inhibitor, With or Without Concomitant Thiazide Diuretic Therapy

A Fifty-Two Week, Multicenter, Double-blind, Placebo-Controlled, Parallel-Group Study to Compare the Effects of an Investigational Medication With Those of Placebo in Mild to Moderate Obese Patients Whose Hypertension is Controlled by a Calcium-Channel Blocker, With or Without Concomitant Thiazide Diuretic Therapy

A Study to Assess the Safety, Tolerability, and Efficacy of An Investigational Medication in Obese Patients

A Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Effects of an Oral Investigational Medication in Subjects With Peripheral Symmetrical Diabetic Polyneuropathy

A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase 2 Study Designed to Assess the Efficacy and Safety of An Investigational Medication in Subjects with Painful Diabetic Neuropathy

A Fifty-Two Week, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Study to Compare the Effects of an Investigational Medication With Those of Placebo in Mild to Moderate Obese Patients Whose Hypertension is Controlled by an Angiotensin-Converting Enzyme Inhibitor, With or Without Concomitant Thiazide Diuretic Therapy

A Randomized, Double-Blind, Parallel Group Evaluation of an Investigational Medication compared to Fluvastatin 40 mg and Placebo Daily in Patients with Hypercholesterolemia

A Study to Evaluate the Safety and Efficacy of an Investigational Medication in the Treatment of Obese Type II Diabetics Maintained on Oral Hypoglycemic Agents

A 20 week, Double-Blind, Randomized Study of an Investigational Medication in Patients With Non-Insulin Dependent Diabetes

A 12 week, Double-Blind Study of an Investigational Medication Versus Placebo in Noninsulin-Dependent Diabetes Mellitus Patients Requiring Insulin

Fifty-Two Week, Multicenter, Double-Blind, Parallel Group, Placebo-Controlled and an Investigational Medication Dose Ranging Study to Evaluate Glycated Hemoglobin in Patients With Type II Diabetes Mellitus

A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety, Tolerability, and Efficacy of An Investigational Nasal Spray in Obese Patients

A Two-Year Study (One Year Weight Loss followed by One Year Prevention of Weight Regain) to Assess the Safety, Tolerability and Efficacy of An Investigational Medication In Obese Patients